Serum syndecan-1 correlates with coronary artery calcification severity and intradialytic hypotension in elderly hemodialysis patients
Frontiers in Cardiovascular Medicine · 11.06.2026 · 13
DOI: 10.3389/fcvm.2026.1842977 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 11.06.2026. Verfasst von Dian Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Affiliated Huai'an Hospital of Xuzhou Medical University and Huai'an Second People's Hospital, Huai'an, China. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and objectives Cardiovascular disease is the leading mortality cause in elderly maintenance hemodialysis (MHD) patients, driven by coronary artery calcification (CAC). Elevated serum syndecan-1 (SDC1), a biomarker of endothelial glycocalyx degradation, indicates vascular dysfunction. This study explored the cross-sectional associations between serum SDC1, CAC severity, and intradialytic hypotension (IDH) in this population. Materials and methods This cross-sectional study enrolled 88 elderly MHD patients and 30 healthy controls. Serum SDC1 was quantified, and CAC severity was assessed via computed tomography coronary artery calcium scores (CACS). IDH episodes were retrospectively reviewed from 3-month standardized dialysis records. Associations were analyzed using Spearman's correlation and multivariable ordinal logistic regression with a clinically prespecified sequential adjustment strategy. The discriminative stability of SDC1 was internally validated using the bootstrap resampling method.
Results
Serum SDC1 was significantly higher in MHD patients than controls ( P < 0.001). SDC1 strongly correlated with CACS ( r = 0.75, P < 0.001), increasing progressively across CAC severity strata. After adjusting for demographics, clinical history, and mineral metabolism markers, elevated SDC1 was independently associated with greater CAC severity (Adjusted OR = 1.148, 95% CI 1.096–1.202, P < 0.001). Exploratory ROC analysis yielded a robust bootstrap-validated AUC of 0.920 (95% CI 0.867–0.974). An exploratory SDC1 threshold of 33.5 pg/mL identified a phenotype with higher CAC prevalence (86.9% vs. 7.4%, P < 0.001) and more frequent IDH episodes ( P < 0.001).
Conclusions
Elevated serum SDC1 is independently associated with CAC severity and IDH incidence in elderly MHD patients. These findings suggest that SDC1, reflecting endothelial glycocalyx degradation, may serve as a potential indicator of vascular and hemodynamic instability. However, its exploratory role in risk assessment requires further prospective validation in independent cohorts before clinical application.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, The Affiliated Huai'an Hospital of Xuzhou Medical University and Huai'an Second People's Hospital, Huai'an, China.
- Department of Nephrology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huai'an, China.
- Special Needs Ward, The Affiliated Huai'an Hospital of Xuzhou Medical University and Huai'an Second People's Hospital, Huai'an, China.
Zitieren
APA
Zhu, D., Zhang, Y., Song, Y., Xi, Y., Zhu, M., Li, H., Zheng, D., & Zhao, X. (2026). Serum syndecan-1 correlates with coronary artery calcification severity and intradialytic hypotension in elderly hemodialysis patients. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1842977
Vancouver
Zhu D, Zhang Y, Song Y, Xi Y, Zhu M, Li H, et al. Serum syndecan-1 correlates with coronary artery calcification severity and intradialytic hypotension in elderly hemodialysis patients. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1842977
BibTeX
@article{Zhu2026,
author = {Zhu, Dian and Zhang, Yiyuan and Song, Yu and Xi, Yu and Zhu, Mingzhe and Li, Hailun and Zheng, Donghui and Zhao, Xue},
title = {Serum syndecan-1 correlates with coronary artery calcification severity and intradialytic hypotension in elderly hemodialysis patients},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1842977}
}
EUVIMED